CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells
This study reports the CD44 receptor-targeted gold-doxorubicin nanocomposite (<i><sub>T</sub></i>GNC-DOX) for pulsatile chemo-photothermal therapy of triple-negative breast cancer (TNBC). The developed <i><sub>T</sub></i>GNC-DOX was nanometric, having...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/12/2734 |